Kannan Kashi Vishwanath
Corporate Officer/Principal at Indo-American Chamber of Commerce & Industry
Profile
Dr. Kannan Kashi Vishwanath is Vice Chairman & Managing Director at Dr. Datsons Labs Ltd.
and a Member at Indo-American Chamber of Commerce & Industry.
He is on the Board of Directors at Dr. Datsons Labs Ltd.
and Finaventure Capital Ltd.
He received his undergraduate degree from the University of Pune, an MBA from Hamilton College (New York), and a doctorate degree from The International University.
Kannan Kashi Vishwanath active positions
| Companies | Position | Start |
|---|---|---|
| Indo-American Chamber of Commerce & Industry | Corporate Officer/Principal | 2011-06-16 |
Former positions of Kannan Kashi Vishwanath
| Companies | Position | End |
|---|---|---|
| FINAVENTURE CAPITAL LTD | Chief Executive Officer | 2015-02-13 |
| DR DATSONS LABS LTD | Founder | 2014-08-20 |
Training of Kannan Kashi Vishwanath
| Hamilton College (New York) | Masters Business Admin |
| University of Pune | Undergraduate Degree |
| The International University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Indo-American Chamber of Commerce & Industry | |
Finaventure Capital Ltd.
 Finaventure Capital Ltd. Investment ManagersFinance Finaventure Capital Ltd. is an investment company, which engages in the business of investments in listed and unlisted companies. The company was founded on January 19, 1985 and is headquartered in Mumbai, India. | Finance |
Dr.Datsons Labs Ltd.
 Dr.Datsons Labs Ltd. Pharmaceuticals: MajorHealth Technology Dr. Datsons Labs Ltd. engages in the manufacture, and market of contract research and manufacturing services (CRAMS), and active pharmaceutical ingredients (API). It operates through the following segments: Active Pharmaceutical Ingredients (API), Formulation, and Trading. The API segment manufactures second generation anti-malaria APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The company was founded by Kannan Kashi Vishwanathan on January 3, 2006 and is headquartered in Mumbai, India. | Health Technology |
- Stock Market
- Insiders
- Kannan Kashi Vishwanath
